Back to News
Market Impact: 0.2
3 Biotech Stocks Put Traders Are Targeting Today
Source: schaeffersresearch.com
Healthcare & BiotechFutures & OptionsDerivatives & VolatilityMarket Technicals & Flows
Nektar Therapeutics, Quantum-Si, and Pacific Biosciences are seeing elevated options activity amid volatile trading in biotech shares. The article provides no specific contract volumes, price moves, or identified catalyst, limiting the immediate fundamental read-through beyond increased speculative positioning.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
NKTR0.10
PACB0.05
QSI0.05
More News
- US borrowing costs hit 24-year high as global bond sell-off intensifies
- These charts show how volatile the last quarter was for stocks and bonds
- Economy 'Running Firm', Not Overheating: Roth
- Investors Are Driving Government Bond Yields Higher
- Bond yields suddenly retreat from recent highs as buyers step back into the Treasury market
- One of our most recent defensive buys cleared a hurdle and its stock jumped
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: AI-Powered Report Editing, Investor Relations, and Enhanced Search
- Automating Financial Model Updates: A Source-Controlled Workflow